DENTSPLY SIRONA Inc. - Common Stock (XRAY)
15.33
-0.58 (-3.65%)
Dentsply Sirona Inc is a global leader in the dental industry, specializing in the manufacturing and distribution of a wide range of dental products and technologies
The company provides innovative solutions for dental professionals, including equipment, instruments, and materials used in various dental procedures, such as restorative, preventive, and orthodontic care. Dentsply Sirona focuses on improving patient outcomes through advancements in dental technology, offering products that enhance treatment efficiency and effectiveness. By catering to dental professionals worldwide, the company plays a pivotal role in enhancing oral health and clinical practice standards.

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Via StockStory · March 11, 2025

Let’s dig into the relative performance of Align Technology (NASDAQALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season.
Via StockStory · March 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQHSIC) and the best and worst performers in the dental equipment & technology industry.
Via StockStory · March 4, 2025

Via Benzinga · February 28, 2025

Via Benzinga · January 30, 2025

Via Benzinga · December 4, 2024

Dental products company Dentsply Sirona (NASDAQXRAY) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 10.6% year on year to $905 million. The company’s full-year revenue guidance of $3.55 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 40.1% below analysts’ consensus estimates.
Via StockStory · February 27, 2025

Dentsply Sirona Q4 earnings miss estimates with a 10% sales drop, and the company forecasts lower 2025 sales.
Via Benzinga · February 27, 2025

Dental products company Dentsply Sirona (NASDAQXRAY)
will be announcing earnings results tomorrow morning. Here’s what you need to know.
Via StockStory · February 26, 2025

Via Benzinga · February 14, 2025

Via Benzinga · January 23, 2025

Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition.
Via Benzinga · December 12, 2024

Via Benzinga · December 10, 2024

Via Benzinga · November 7, 2024

Via Benzinga · November 7, 2024

Dentsply Sirona Q3 earnings beat estimates, but a $495M goodwill impairment and lowered sales outlook cause stock to drop 22%.
Via Benzinga · November 7, 2024

Via Benzinga · October 28, 2024

Via Benzinga · August 20, 2024

Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand.
Via Benzinga · July 31, 2024

XRAY stock results show that Dentsply Sirona missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 31, 2024